2Marrow DA,Rifai N,Antman EM,et al .C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes:a TIMIⅡA subsdudy.J Am Coll Cardiol,1998,31:1460-1465.
3Kuller LH,Tracy RP,Shaten J,et al .Relation of C-reactive protein and coronary heart disease in the MRFIT nested case control study.Am J epidemiol,1996,144;537-547.
二级参考文献25
1National Heart,Lung,and Blood Institute Fact Book. Fiscal Year 1995. US Department of Heart and Human Service Monogragh. March,1996:30～52
2Farmer JA,Gotto AM Jr. Dyslipidemia and other risk factors for coronary artery disease. In:Braunwald E,editor. Heart Disease:A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia:Saunders,1997.1126～1160
3Robinson K, Mayer EL,Miller DP,et al. Hyperhomocysteinemia and low pyridoxal phospate:common and independent reversible risk factors for coronary artery disease. Circulation, 1995,92:2825～2830
4Ross R. Ceel biology of atherosclerosis. Annu Rev Physiol, 1995,57:791～804
5Van der Wal AC,Becker AE, Van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammation process irrespective of the dominant plaque morphology. Circulation, 1994,89:36～44
6Shah PK,Falk E,Badimon JJ,et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques:potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation, 1995,92:1565～1569
7Maseri A. Inflammation,atherosclerosis,and ischemic events-exploring the hidden side of the moon. N Engl J Med, 1997,336:1014～1016
8Berk BC,Weintraub WS,Alexander RW. Elevation of reactive protein in "active"coronary artery disease. Am J Cardiol, 1990,65:168～172
9de Beer FC,Hind CR,Fox KM, et al. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J, 1982,47:239～243
10Pietila K,Marmoinen A,Hermens W, et al. Serum C-reactive protein concentration in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart, 1993,14:915～919
8Guijarro C. High-sensitivity C-reactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease [J].Circulation,2001,104(22):E127.
9Bickel C ,Rupprecht HJ ,Blankcnberg S,et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease[J] . AmJ Cardiol,2002,89 (1):12-17.
